Mubadala to significantly increase investment in life sciences, medical technology

ABU DHABI (Reuters) – Abu Dhabi state investor Mubadala will significantly increase investment in life sciences and medical technology as it sees the healthcare sector as profitable, its group chief executive said on Tuesday.

“You’ll see us significantly increase our investment in that space,” Khaldoon Khalifa al-Mubarak told an investment conference in Abu Dhabi.

Mubadala, which owns Cleveland Clinic in Abu Dhabi, last year acquired Amana Healthcare, a provider of long-term care, specialized rehabilitation, and home healthcare services.

Mubadala, which manages about $240 billion in assets, is the second-biggest state investor after Abu Dhabi Investment Authority, which is estimated to have nearly $700 billion in assets.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.